CIK 0001585364 · Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-13 | Doyle Katherine C. Director | Sale | −8,954 | $27.30 | $244K | 6,009 |
| 2024-09-09 | Ball David EVP & CBDO | Grant or award · Restricted Stock Units | +15,402 | 15,402 | ||
| 2024-08-26 | Janish Ronald Craig EVP, Gbl Ops & SC & CTO | Sale | −13,000 | $29.40 | $382K | 20,553 |
| 2024-08-20 | Andersen Svend EVP & President CHCI | Sale | −20,500 | $27.86 | $571K | 81,353 |
| 2024-08-20 | Andersen Svend EVP & President CHCI | Sale | −7,800 | $27.46 | $214K | 73,553 |
| 2024-08-20 | Andersen Svend EVP & President CHCI | Sale | −6,683 | $27.43 | $183K | 7,000 |
| 2024-07-10 | Lockwood-Taylor Patrick CEO | Option exercise | +28,326 | $27.16 | $769K | 48,826 |
| 2024-07-10 | Lockwood-Taylor Patrick CEO | Shares withheld for taxes | −10,974 | $27.16 | $298K | 37,852 |
| 2024-07-10 | Lockwood-Taylor Patrick CEO | Grant or award | +11,837 | $27.16 | $321K | 49,689 |
| 2024-07-10 | Lockwood-Taylor Patrick CEO | Shares withheld for taxes | −4,280 | $27.16 | $116K | 45,409 |
| 2024-07-10 | Lockwood-Taylor Patrick CEO | Option exercise · Restricted Stock Units | −28,326 | 56,651 | ||
| 2024-07-08 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +920 | $25.72 | $24K | 18,930 |
| 2024-07-08 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −479 | $25.72 | $12K | 18,451 |
| 2024-07-08 | Ives Alison EVP & Chief Scientific Officer | Option exercise · Restricted Stock Units | −920 | 919 | ||
| 2024-06-07 | KINGMA TODD W Executive VP, General Counsel | Grant or award · Restricted Stock Units | +21,715 | 21,715 | ||
| 2024-06-07 | Bezerra Eduardo Guarita EVP & Chief Financial Officer | Option exercise | +4,532 | $26.94 | $122K | 16,563 |
| 2024-06-07 | Bezerra Eduardo Guarita EVP & Chief Financial Officer | Shares withheld for taxes | −1,104 | $26.94 | $30K | 15,459 |
| 2024-06-07 | Bezerra Eduardo Guarita EVP & Chief Financial Officer | Option exercise · Restricted Stock Units | −4,532 | 4,531 | ||
| 2024-05-28 | Andersen Svend EVP & President CHCI | Purchase | +1,000 | $27.90 | $28K | 101,853 |
| 2024-05-15 | Parker Geoffrey M. Director | Option exercise | +8,764 | $30.22 | $265K | 24,469 |
Page 15 of 27 · 524 trades